de Vries L - Search Results

1

Biosynthesis of lanthionine-constrained agonists of G protein-coupled receptors.

Moll GN, Kuipers A, Rink R, Bosma T, de Vries L, Namsolleck P. Moll GN, et al. Among authors: de vries l. Biochem Soc Trans. 2020 Oct 30;48(5):2195-2203. doi: 10.1042/BST20200427. Biochem Soc Trans. 2020. PMID: 33125486 Free PMC article. Review.

2

Angiotensin-(1-7) with thioether bridge: an angiotensin-converting enzyme-resistant, potent angiotensin-(1-7) analog.

Kluskens LD, Nelemans SA, Rink R, de Vries L, Meter-Arkema A, Wang Y, Walther T, Kuipers A, Moll GN, Haas M. Kluskens LD, et al. Among authors: de vries l. J Pharmacol Exp Ther. 2009 Mar;328(3):849-54. doi: 10.1124/jpet.108.146431. Epub 2008 Nov 26. J Pharmacol Exp Ther. 2009. PMID: 19038778

3

Oral and pulmonary delivery of thioether-bridged angiotensin-(1-7).

de Vries L, Reitzema-Klein CE, Meter-Arkema A, van Dam A, Rink R, Moll GN, Akanbi MH. de Vries L, et al. Peptides. 2010 May;31(5):893-8. doi: 10.1016/j.peptides.2010.02.015. Epub 2010 Mar 3. Peptides. 2010. PMID: 20206220

4

Bacterial display and screening of posttranslationally thioether-stabilized peptides.

Bosma T, Kuipers A, Bulten E, de Vries L, Rink R, Moll GN. Bosma T, et al. Among authors: de vries l. Appl Environ Microbiol. 2011 Oct;77(19):6794-801. doi: 10.1128/AEM.05550-11. Epub 2011 Aug 5. Appl Environ Microbiol. 2011. PMID: 21821759 Free PMC article.

5

The antitumor activity of hydrophobin SC3, a fungal protein.

Akanbi MH, Post E, van Putten SM, de Vries L, Smisterova J, Meter-Arkema AH, Wösten HA, Rink R, Scholtmeijer K. Akanbi MH, et al. Among authors: de vries l. Appl Microbiol Biotechnol. 2013 May;97(10):4385-92. doi: 10.1007/s00253-012-4311-x. Epub 2012 Jul 31. Appl Microbiol Biotechnol. 2013. PMID: 22846904

6

Agonists of MAS oncogene and angiotensin II type 2 receptors attenuate cardiopulmonary disease in rats with neonatal hyperoxia-induced lung injury.

Wagenaar GT, Laghmani el H, Fidder M, Sengers RM, de Visser YP, de Vries L, Rink R, Roks AJ, Folkerts G, Walther FJ. Wagenaar GT, et al. Among authors: de visser yp, de vries l. Am J Physiol Lung Cell Mol Physiol. 2013 Sep;305(5):L341-51. doi: 10.1152/ajplung.00360.2012. Epub 2013 Jun 28. Am J Physiol Lung Cell Mol Physiol. 2013. PMID: 23812633 Free PMC article.

7

Semi-microbiological synthesis of an active lysinoalanine-bridged analog of glucagon-like-peptide-1.

Kuipers A, de Vries L, de Vries MP, Rink R, Bosma T, Moll GN. Kuipers A, et al. Among authors: de vries mp, de vries l. Peptides. 2017 May;91:33-39. doi: 10.1016/j.peptides.2017.03.004. Epub 2017 Mar 12. Peptides. 2017. PMID: 28300673

8

LP2, a cyclic angiotensin-(1-7) analog extended with an N-terminal D-lysine, impairs growth of patient-derived xenografts of colorectal carcinoma in mice.

Namsolleck P, de Vries L, Moll GN. Namsolleck P, et al. Among authors: de vries l. Peptides. 2023 Feb;160:170920. doi: 10.1016/j.peptides.2022.170920. Epub 2022 Dec 6. Peptides. 2023. PMID: 36493954

9

Antagonism of HSV-tk transfection and ganciclovir treatment on chemotherapeutic drug sensitivity.

Van Dillen IJ, Mulder NH, Meijer C, Dam WA, Kamstra E, De Vries L, Meersma GJ, Van der Zee AG, De Vries EF, Vaalburg W, Hospers GA. Van Dillen IJ, et al. Among authors: de vries ef, de vries l. J Chemother. 2005 Jun;17(3):289-96. doi: 10.1179/joc.2005.17.3.289. J Chemother. 2005. PMID: 16038523

10

Pharmacokinetics of high-dose teniposide.

Holthuis JJ, de Vries LG, Postmus PE, van Oort WW, Verleun H, Hulshoff A, Sleijfer DT, Mulder NH. Holthuis JJ, et al. Among authors: de vries lg. Cancer Treat Rep. 1987 Jun;71(6):599-603. Cancer Treat Rep. 1987. PMID: 3581097

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

969 results

Search Page